NasdaqGS:PRVAHealthcare
A Fresh Look at Privia Health Group (PRVA) Valuation Following Raised 2025 Revenue Guidance and Strong Q3 Results
Privia Health Group (PRVA) just released its third-quarter earnings, showing strong year-over-year growth in both revenue and profits. The company also raised its revenue outlook for the full year, signaling confidence in ongoing performance.
See our latest analysis for Privia Health Group.
Following the upbeat earnings report and raised revenue guidance, Privia Health Group’s 16.5% share price return over the last 90 days stands out, even as the 1-year total shareholder return sits at 6.4%...